肠道微生物群：炎症性肠病与代谢相关脂肪性肝病之间的致病桥梁。 - Suppr

Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease.

作者信息

Scarlata Giuseppe Guido Maria, Abenavoli Ludovico

机构信息

Department of Health Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.

出版信息

Expert Rev Gastroenterol Hepatol. 2025 Jan-Feb;19(2):85-88. doi: 10.1080/17474124.2025.2464037. Epub 2025 Feb 7.

DOI:10.1080/17474124.2025.2464037

PMID:39907629

Abstract

摘要

相似文献

Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease.

Expert Rev Gastroenterol Hepatol. 2025 Jan-Feb;19(2):85-88. doi: 10.1080/17474124.2025.2464037. Epub 2025 Feb 7.

Crohn's Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review.

Cureus. 2023 Aug 5;15(8):e42995. doi: 10.7759/cureus.42995. eCollection 2023 Aug.

Evaluation of plasma Short chain fatty acid levels as markers for Inflammatory bowel disease.

Scand J Gastroenterol. 2023 Jul-Dec;58(11):1246-1252. doi: 10.1080/00365521.2023.2219357. Epub 2023 Jun 5.

Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay.

Nutrients. 2022 Dec 15;14(24):5323. doi: 10.3390/nu14245323.

Diet and gut microbiota manipulation for the management of Crohn's disease and ulcerative colitis.

Proc Nutr Soc. 2021 Sep 23:1-15. doi: 10.1017/S0029665121002846.

[Gut-liver axis in inflammatory bowel disease. A retrospective study].

Orv Hetil. 2017 Jul;158(26):1014-1021. doi: 10.1556/650.2017.30781.

Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.

Cell Mol Gastroenterol Hepatol. 2016 Mar 3;2(4):468-481. doi: 10.1016/j.jcmgh.2016.02.003. eCollection 2016 Jul.

Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains.

BMC Microbiol. 2024 Jun 29;24(1):233. doi: 10.1186/s12866-024-03368-4.

INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.

Acta Clin Croat. 2020 Mar;59(1):67-80. doi: 10.20471/acc.2020.59.01.09.

Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inﬂammatory bowel disease in tertiary center.

Rev Assoc Med Bras (1992). 2024 Jul 19;70(6):e20231321. doi: 10.1590/1806-9282.20231321. eCollection 2024.

引用本文的文献

Comment on Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut-Liver Axis. 2025, , 288.

Life (Basel). 2025 Jul 30;15(8):1210. doi: 10.3390/life15081210.

Metabolic and hepatic biomarkers associated with MASLD in the Chinese population.

Sci Rep. 2025 Aug 27;15(1):31593. doi: 10.1038/s41598-025-17219-3.

Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases.

J Clin Med. 2025 Apr 25;14(9):2973. doi: 10.3390/jcm14092973.

Targeting the Gut-Brain Axis with Plant-Derived Essential Oils: Phytocannabinoids and Beyond.

Nutrients. 2025 May 3;17(9):1578. doi: 10.3390/nu17091578.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献